Evidence map›Paper›PMID 31190821›Full record

ArticleInternational journal of nanomedicine2019

Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors.

Mona Ahmed, Roland Baumgartner, Silvia Aldi, Philip Dusart, Ulf Hedin, Björn Gustafsson, Kenneth Caidahl

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mona AhmedDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE 17176, Stockholm, Sweden.
Roland BaumgartnerDepartment of Medicine Solna, Karolinska Institutet, SE 17176, Stockholm, Sweden.
Silvia AldiSection for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE 17177, Stockholm, Sweden.
Philip DusartDepartment of Cellular and Clinical Proteomics, Science for Life Laboratory, Kungliga Tekniska Högskolan (KTH), SE 17165, Stockholm, Sweden.
Ulf HedinDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE 17176, Stockholm, Sweden.
Björn GustafssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE 17176, Stockholm, Sweden.
Kenneth CaidahlDepartment of Molecular Medicine and Surgery, Karolinska Institutet, SE 17176, Stockholm, Sweden.
Karolinska Institutet · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Molecular Targeted TherapyAnimalsEndocytosisHumansMacrophagesMaleatesMolecular ProbesPhagocytosisScavenger Receptors, Class BSerum Albumin, HumanTHP-1 CellsTissue DistributionMaleatesmaleylated serum albumin, humanMolecular ProbesScavenger Receptors, Class BSerum Albumin, Humanatherosclerosisinflammationmacrophagemolecular imagingscavenger receptorzirconium

Identifiers

PMID31190821
PMCPMC6535103
OpenAlexW2945363049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.